| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  The EBMT We are a non-profit medical and scientific organisation for cellular and stem cell-based therapies. Join our community! The EBMT is a non-profit medical and scientific organisation established in 1974 which hosts a unique patient registry providing a pool of data to perform studies and assess new trends. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit www.ebmt.org to learn … Type: | 0 | 0 | 0 | 187 |
 | Elixirgen Scientific Transform how you model human biology. Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human … Type: | 1 | 1 | 0 | 23 |
 | IceCure Medical The Choice of Cryoablation IceCure Medical is a medical device company innovating cryotherapy solutions to treat benign & malignant tumors with our liquid nitrogen based ProSenseTM Cryoablation System for women’s health and interventional oncology. #freezecancernotyourlife Founded in 2006 to advance the treatment of cancerous tumors, our FDA-cleared and CE-marked ProSenseTM Cryoablation System utilizes liquid nitrogen to generate ultra-cold temperatures quickly to create large lethal zones for maximum efficacy in tumor destruction. The system achieves a sharp temperature decrease at the start of the freeze step and provides consistently stable freezing temperatures throughout the procedure. ProSense is a proven solution for … Type: | 0 | 0 | 0 | 74 |
 | ObsEva SA ObsEva. Nature meets Nurture Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. Type: | 0 | 0 | 0 | 12 |
 | Silence Therapeutics plc Our 20-plus years of RNAi experience together with our validated mRNAi GOLDTM platform make us a partner of choice for pharmaceutical companies looking to access the benefits of the siRNA and add this revolutionary modality to their discovery pipeline. As pioneers in the design and development of siRNAs (short interfering RNAs), Silence Therapeutics is advancing a new generation of medicines to potentially address the needs of patients who have limited or inadequate treatment options. Our mission is to use our technology to create a new generation of therapeutics which can improve outcomes for patients and, in the process, build shareholder … Type: | 0 | 0 | 0 | 107 |
 |  Cartesian Therapeutics Pioneering RNA cell therapy for autoimmune disease In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly owned pipeline, including Descartes-08, Cartesian’s clinical-stage lead product candidate being evaluated in patients with myasthenia gravis and other autoimmune diseases. For more information about the company and updates, please visit https://www.cartesiantherapeutics.com/ or follow us on LinkedIn @Cartesian-Therapeutics. Immunotherapy, Oncology, Molecular Biology, Immunology, Autoimmune Diseases, Myasthenia Gravis, ARDS, Cell Therapy, Lung disease, NETs, Cardiovascular Disease, Gene Therapy, Cancer Research, … Type: | 0 | 0 | 0 | 51 |
 | BioNTech IMFS BioNTech Innovative Manufacturing Services (IMFS) is a subsidary of BioNTech SE. We are specialized in the development and production of innovative products (viral vectors, cells and ivt mRNA). Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facilities. We offer contract services for retroviral vector manufacturing for clinical supply. The company has more than 500 experienced and highly skilled employees and is always looking for motivated people! See also www.biontech-imfs.de Cell therapy, GMP manufacturing, Gene Therapy, RNA manufacturing, Retroviral vector manufacturing, Contract Manufacturing, … Type: | 0 | 0 | 0 | 241 |
 | SIRNAOMICS Sirnaomics is an RNA therapeutics biopharmaceutical company that focuses on the discovery and development of innovative drugs for indications with unmet medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both Asia and the United States. Based on its proprietary delivery technologies, a polypeptide nanoparticle RNAi platform and GalNAc RNAi platform, GalAheadTM, Sirnaomics has established an enriched drug candidate pipeline. STP122G, which represents the first drug candidate utilizing the Group's GalAheadTM mxRNA technology, is currently in Phase I development. STP125G is the second siRNA therapeutics based on Sirnaomics proprietary … Type: | 0 | 0 | 0 | 48 |
 | Biomica Ltd. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform. Type: | 0 | 0 | 0 | 21 |
 | Oisin Biotechnologies Using using senolytic technology to combat age-related diseases. Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that … Type: | 0 | 0 | 0 | 17 |
 | BioAge Labs We are harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses >65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as … Type: | 2 | 1 | 1 | 87 |
 | cellvie Levearging the therapeutic potential of mitochondria cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation. Therapeutic Mitochondria Transfer, Mitochondria, Ischemia-Reperfusion Injury, and Solid Organ Transplantation Type: | 2 | 0 | 2 | 10 |
 | Kura Oncology, Inc. Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives. Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment … Type: | 0 | 0 | 0 | 199 |
 | Gritstone bio A clinical-stage biotech company that aims to develop the world’s most potent vaccines for cancer and infectious disease Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to develop the next-generation of vaccines for cancer and infectious disease. With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on tumor-specific neoantigens and … Type: | 0 | 0 | 0 | 162 |
 | Cellarity Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas … Type: | 1 | 0 | 1 | 135 |
 | ZEBRA MEDICAL Caring For Life. We go beyond the conventional role of providing medical devices. Medical device manufacturer and distributor of specialised products mainly in the fields of oncology, pain management, ultrasound and cellAED Type: | 0 | 0 | 0 | 12 |
 | Camena Bioscience Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis Type: | 0 | 0 | 0 | 30 |
 | Nuclera Bring rapid protein access to your benchtop with eProtein Discovery At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein DiscoveryTM system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology … Type: | 7 | 1 | 4 | 130 |
 | MyoKardia Driven by the heart We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W Genetic Heart Disease, Cardiomyopathy, biotechnology, cardiovascular disease, heart failure, precision medicine, therapeutics, drug discovery, drug development, and R&D Type: | 1 | 0 | 1 | 36 |
 | Geltor Geltor is the biodesign company powering the products of the future with effective, sustainable, animal-free proteins Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance. Biotechnology, Protein, Cosmetics, Personal … Type: | 1 | 0 | 0 | 30 |
 | DIANA Biotechnologies Advancing clinical diagnostics and drug discovery We are leading Czech biotechnology company with a great innovative potential. We focus on the development of products based on our cutting edge research in the fields of molecular diagnostics and drug discovery. We have global ambitions and since our foundation in 2018 we already have achieved some of our goals. During COVID-19 pandemics, we were able to quickly develop one of the most innovative COVID-19 tests worldwide and we helped to increase the testing capacity of the whole country. As a result, we became the biggest Czech manufacturer of RT-PCR tests. Besides RT-PCR, … Type: | 3 | 0 | 3 | 61 |
 | TriviumVet Bridging the treatment gaps in veterinary care for companion animals TriviumVet are an animal therapeutics company headquartered in Waterford, Ireland. We work with human healthcare and pharmaceutical businesses to bring healthcare applications to the veterinary market including: - veterinary pharmaceuticals, - veterinary medical devices and - veterinary diagnostic solutions Our pipeline includes patented, proprietary technology and pharmaceuticals that are completing European Medical Agency and Food and Drug Administration regulatory pathways. We develop in house research but also work with leading human healthcare companies. You can follow us online @triviumvet on Facebook, Twitter and Linkedin veterinary, pharmaceuticals, research and development, innovation, … Type: | 6 | 0 | 1 | 16 |
 | SNIPR Biome - A CRISPR Company Clinical CRISPR and Gene Therapy of the Microbiome Company We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future. Type: | 3 | 0 | 3 | 43 |
 | Galecto, Inc. Clinical stage fibrosis and cancer treatments Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases. Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM … Type: | 3 | 0 | 1 | 34 |
 | Absci Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as … Type: | 7 | 0 | 8 | 180 |
 | Beanfields The Positively Addicting Bold Bean Chip. Beanfields is on a mission to inspire the world to upgrade their snacking habits with crunchy, mouth-watering BEAN-BASED chips that are POSITIVELY ADDICTING and deeply nutritious. Every bag of Beanfields chips is full on flavor, packed with protein and fiber, Non-GMO, gluten free, and vegan. Finally, an addiction you can feel good about. Beanfields are currently sold throughout all 50 states, Canada, and other countries. We have a unique social impact partnership with Homeboy Industries, the largest and preeminent gang rehabilitation and re-entry program in the world. Bean and Rice Chips, Gluten-Free Snacks, Vegan … Type: | 2 | 0 | 1 | 4 |
 | Grupo Español de Cáncer de Pulmón [Automatic translation follows] Lung Cancer Research The Spanish Lung Cancer Group (GECP) is a cooperative work and research group in this pathology made up of more than 460 professionals that enjoys a high position both nationally and internationally. Research to achieve more effective treatments against the disease is one of the main missions and values of the GECP. A work that is carried out from its administrative headquarters. Since its launch, the GECP headquarters has led, developed and monitored studies and trials in different clinical situations, from the initial stages of the disease to the most advanced, in which more … Type: | 1 | 0 | 1 | 29 |
 | Sonoma Biotherapeutics Leading the Next Frontier of Cell Therapy Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle. Type: | 1 | 1 | 1 | 133 |
 | Chittick Family Eye Care The Doctors and Staff of Chittick Family Eye Care strive to provide each patient with excellence in vision and eye health care. We guarantee our constant commitment to the visual wellness of our patients by extending thorough diagnostic and therapeutic eye care, by emphasizing personalized service, and by never compromising materials, value, or professionalism Chittick Family Eye Care provides superb care for your eyes. From contacts, glasses and LASIK consultation to pediatric eye care, cataracts and vision therapy, we provide comprehensive care for the eye care of your entire family. Optometry, Contact Lenses, Eye Disease Prevention and Management, Eye Examinations, … Type: | 0 | 0 | 0 | 43 |
 | Akin (formerly Children's Home Society of Washington) Our Purpose:We work to disrupt systemic and multi-generational cycles of inequity by partnering with children, families Children's Home Society of Washington and Childhaven, have merged to become Akin. This merger allows us to grow and evolve as one organization, not for the sake of size but for the scope of direct impact in our commitment and partnership to and for children, families and communities. Visit us at our new website: www.akinfamily.org. early learning, family support programs, child and family counseling, therapeutic foster care, adoption services, search and reunion, advocacy for children, and Wendy's Wonderful Kids Type: | 2 | 0 | 2 | 241 |
 | BioTek Instruments BioTek is worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. BioTek, now a part of Agilent Technologies, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. Life Science instrumentation and automation and software. Type: | 1 | 0 | 1 | 184 |
 | Fermtech Fermenting change Up-cycling spent grains to make proteins for the food industry. Type: | 0 | 0 | 0 | 8 |
 |  Altach (an NLC Venture) Altach is an NLC venture company. At Altach our goal is to become the gold standard in regenerative cartilage technology. We are building a portfolio of biomimetic cartilage grafts allowing surgeons to repair cartilage defects and restore patient’s quality of life. Altach is developing a portfolio of biomimetic cartilage scaffolds utilising Type II collagen which is the building block of native cartilage. The scaffolds are designed to be used stand alone and in conjunction with other cell based therapies. The implants unique composition create a matrix for the patient’s own cells to migrate into and regenerate the cartilage. Medical Devices, … Type: | 0 | 0 | 0 | 2 |
 | Antion Biosciences SA Creating breakthrough therapies. Changing lives. Antion Biosciences SA (Antion) is a Swiss biopharmaceutical company developing novel gene and gene-modified cell therapies to treat and cure diseases with significant unmet medical needs. Our proprietary technologies allow for the creation of multimodal treatments that aim to substantially enhance clinical safety and efficacy. We have a number of products in preclinical development, and it is our mission to translate our proprietary technologies into meaningful therapies for the benefit of patients. We are fully committed to creating high-value therapeutic assets, while developing strategies to ensure broad accessibility of our treatments, especially to resource poor … Type: | 0 | 0 | 0 | 18 |
 | Rostra Therapeutics Restore health and save lives through innovative medicines Rostra strives urgently to bring novel medicines to patients and clinicians with the power to restore health and save lives globally. Through its novel technology platform, Rostra is developing medicines for infectious diseases with an initial focus on invasive fungal infections. Pharmaceutical Discovery & Drug Development and Infectious Disease Type: | 0 | 0 | 0 | 2 |
 | CasInvent Pharma Novel Treatment of Leukemias, Lymphomas and Solid Tumors with Highly Potent and Selective Inhibitors of CK1 Kinases The mission of CasInvent Pharma is to bring new therapeutic options for the treatment of selected leukemias to market. We are developing highly selective small molecule inhibitors of casein kinase I (CK1), and our main development program is focused on the identification of new drugs for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). CasInvent Pharma was established in 2020 as a spin-off company of Masaryk University in cooperation with the investment partner i&i Prague. Type: | 0 | 0 | 0 | 7 |
 | ProteinLogic Ltd ProteinLogic has developed a novel technology platform (ImmiPrint®) focused on the diagnosis of tuberculosis (TB). Along with HIV/AIDS, TB is the most significant infectious disease worldwide. Early and accurate diagnosis is essential for its control. The ImmiPrint® platform has the potential to deliver an effective blood-based TB diagnostic, and to provide information on disease progression. The test may also be able to predict which individuals are likely to respond to anti-microbial therapy. Type: | 0 | 0 | 0 | 1 |
 | Scancell Ltd Using Immunology to Fight Cancer; ImmunoBody® and Moditope® Cancer Vaccines; AvidiMab® and GlyMab® antibody platforms Cancer remains one of the world's most significant diseases. A key challenge in the fight against cancer is that many tumours continue to grow by successfully evading the body's own natural defence mechanism - the immune system. Scancell's mission is to overcome this breach in our defences by developing products that stimulate the immune system to treat or prevent cancer. Type: | 0 | 0 | 0 | 58 |
 | Infinitopes Preventing deaths from cancer metastases Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival. Type: | 2 | 0 | 2 | 28 |
 | Vandria SA We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases Vandria is a biopharmaceutical company that develops best-in-class small molecule mitophagy inducers to treat age-related and chronic diseases in the fields of Muscle- and CNS diseases with large unmet medical need. Type: | 0 | 0 | 0 | 11 |
 | Metrion Biosciences Specialists in ion channel biology Metrion Biosciences is a specialist preclinical drug discovery CRO - your trusted partner for ion channel screening, cardiac safety screening and neuroscience assays. We provide our customers with a range of in vitro screening services, including cardiac safety (GLP hERG, CiPA panel of human cardiac ion channels) and neurotoxicology testing and phenotypic assays on a fee-for-service or collaboration basis. We pride ourselves on being able to provide a flexible and cost effective service with an unparalleled level of expertise. Collectively, we have 250 years experience managing ion channel research programmes. Ion channels, Contract Research (CRO), … Type: | 0 | 0 | 0 | 46 |
 | Medfield Diagnostics AB Medfield Diagnostics AB develops medical devices based on microwave technology. Medfield Diagnostics AB (publ) aims to facilitate a device for decision-support to assist in clinical evaluation and triage of suspected intracranial injuries in the acute situation. This eliminates suffering of affected patients and leads to cost savings due to reduced healthcare and rehabilitation costs. The microwave diagnostic technology can monitor changes and generate images of tissue in the human body. There are many areas where the technology can be valuable, from detecting bleedings and tumors to internal temperature measurements. Microwave diagnostic instruments can be compact compared to other diagnostic techniques, … Type: | 1 | 1 | 0 | 9 |
 | Biohifas We employ the power of mycelium! Biohifas employs the power of mycelium and valorizes industrial side streams into the food. We are developing technology in 3 areas: - Side stream processing into food grade substrates. - Mycelium cultivation in solid state fermentation. - Raw material conservation. We are looking for curious minds, who are amazed by the great kingdom of fungi. Let's employ the power of mycelium and solve the problems that our world faces! fungi, side streams, mycelium, solid state fermentation, side streams, alternative proteins, meat alternatives, circular economy, climate change, industrial by-products, food and beverage, and start up Type: | 2 | 1 | 2 | 4 |
 | BePharBel Manufacturing SA HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder … Type: | 0 | 0 | 0 | 92 |
 | cnsTherapy We make chronic pain patients pain-free using a medical device and behavioral therapy without drugs, surgery, implants. We make chronic pain patients pain-free using a neuromodulation device and behavioral therapy without medication, surgery, implants, or cannabis. pain, behavioral therapy, and fibromyalgia Type: | 0 | 0 | 0 | N/A |
 | Notify Therapeutics Novel treatment paradigm for infertile women. Through targeting of the early and hormone-independent phase of egg maturation, we aim at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. Type: | 0 | 0 | 0 | 10 |
 | Chemify Limited Digitising chemistry and chemical discovery - code to molecules and molecules to code Accelerating molecular discovery through the power of Chemputation. Type: | 1 | 0 | 1 | 78 |
 | GenePlanet A leading European provider of innovative healthcare and lifestyle solutions based on preventive genetic testing. GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests. With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly … Type: | 1 | 0 | 1 | 143 |
 | Celadon Pharmaceuticals Plc UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannabis-based medicines. Celadon Pharmaceuticals Plc is a UK based pharmaceutical company focused on the research, cultivation, manufacturing, and supply of breakthrough cannabis-based medicines. Founded in 2018 after cannabis was legalised for medicinal purposes, Celadon was one of the first companies to receive Home Office and MHRA licences to cultivate and produce high-THC medicines. In March 2022, Celadon listed on the AIM market of the London Stock Exchange – a huge milestone in the industry and the first since GW Pharma (who were acquired for $7bn by Jazz in 2021). … Type: | 1 | 0 | 1 | 19 |
 | Protyon Guiding clinicians towards personalized treatment and enhancing quality of life for patients Using molecular structures to choose the best therapy. Currently focusing on mutations in EGFR and other lung cancer drivers. Working closely with the Molecular Tumor Board at the UMCG #umcg and patient organizations across Europe. Type: | 1 | 0 | 1 | 7 |
 | DEBx Medical Innovating the future of wound care DEBx Medical is a leading innovator in advanced wound care solutions, dedicated to transforming the landscape of wound healing. With a focus on removing infection and biofilm, DEBx Medical pioneers groundbreaking solutions to address the unique challenges of hard-to-heal wounds. Medical devices, Healthcare, Infection, Advanced Wound Care, Wound Care, and Biofilm Type: | 0 | 0 | 0 | 8 |
 | CardioMech AS Mitral Regurgitation is the third most common cardiovascular disease that occurs when there is backward flow of blood across the mitral valve. It is highly prevalent, debilitating for patients, and deadly if untreated. The market is expected to be larger than the TAVR market, currently a $6B market. The CardioMech device is an artificial chord that is designed to reduce or eliminate regurgitation and to restore the native anatomy. This catheter-based therapy is intended to be a simple and straightforward procedure and an alternative therapy option for both patients eligible for open-heart surgery and those considered surgically ineligible. Therefore, the … Type: | 0 | 0 | 0 | 8 |
 | Diamante Società Benefit Srl Plant-based Nanotechnologies for autoimmune diseases diagnoses and therapy DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules. The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications. As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has … Type: | 0 | 0 | 0 | 14 |
 | HVR Cardio Oy HVR Cardio is a medical device company focused on developing first-generation transcatheter mitral valve repair solutions. Our minimally invasive technology has the potential to enable safer, faster, and less traumatic cardiac interventions for mitral regurgitation patients worldwide. HVR Cardio’s innovative HELIX ring technology has been carefully designed to fit the anatomy of the mitral valve. This allows fast and easy implantation and most importantly, restoration of the valve geometry leading to uncompromised clinical efficacy. With our catheter-based product, we expect to reduce the invasiveness, operation time, and morbidity associated with mitral valve repair operations. This would allow effective treatment of … Type: | 0 | 0 | 0 | 12 |
 | MindAhead Early detection and treatment of cognitive impairment Early detection and prevention of cognitive impairments Type: | 1 | 1 | 0 | 5 |
 | Grey Wolf Therapeutics First-of-its-kind antigen modulation to address immune dysfunction in oncology and autoimmunity. Next generation therapeutic approach for immuno-oncology & autoimmune diseases. Grey Wolf was founded by leading scientists, drug developers and investors committed to translating the broad therapeutic potential of ERAP-driven antigen modulation into next generation therapies for patients with immunologically-driven diseases. We are a clinical-stage, UK- and Australia-based drug discovery and development company spearheading a new therapeutic strategy based on a first-of-its-kind approach to antigen modulation. Our innovative technology is centered on inhibiting the endoplasmic reticulum aminopeptidases (ERAP1 and ERAP2), which play a central role in the antigen presentation pathway. … Type: | 1 | 1 | 0 | 34 |
 | Insight Biosolutions Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK Type: | 3 | 2 | 0 | 4 |
 | TRICARES TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system. Type: | 0 | 0 | 0 | 3 |
 | Neumora Pioneering a new era of medicines for brain diseases Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism … Type: | 2 | 0 | 2 | 133 |
 | My Muscle Chef Voted Australia’s best meal delivery service 7 years running, with 100+ high protein fresh meals, snacks +drinks. My Muscle Chef has been fuelling professional athletes and active Australians since 2013 with our award winning, dietitian designed, chef-prepared meals, snacks and drinks. We produce in excess of 2.2 million fresh meals, snacks and drinks for the Australian market each week for delivery to customers' doors and to 6,000+ retail stockists. My Muscle Chef is all about offering smart nutrition that enables you to feel your best. We pair high-quality meals with exceptional taste with the ultimate convenience and ease, allowing you … Type: | 1 | 0 | 1 | 207 |
 | Soi Dog Foundation 20 years saving Asia's dogs & cats through rescue, CNVR, treatment, shelter, adoption & ending the dog & cat meat trade Soi Dog’s mission is 'To improve the welfare of dogs and cats in Asia, resulting in better lives for both the animal and human communities, to create a society without homeless animals and to ultimately end animal cruelty'. Established in 2003 in Phuket, Thailand, Soi Dog is Southeast Asia's largest organisation helping stray animals. The sanctuary in Phuket is currently home to over 1,800 animals. Soi Dog also has a treatment facility in Bangkok and responds to crisis situations … Type: | 1 | 0 | 1 | 79 |
 | PROMETHEE - Hépatites [Automatic translation follows] Hepatitis in the Alpine Arc (38,73,74) Prevention and screening of viral hepatitis and liver diseases. PROMETHEUS Hepatitis in the Alpine arc (Isère, Savoie, Haute Savoie) Health association created in 1999, part of MRSI. Service for the prevention, awareness, screening of viral hepatitis and any other liver disease. Free awareness raising for at-risk or specific audiences, the general public and professionals. Diagnostic-oriented prevention and screening sessions (via TROD and FIBROSCAN®) with partners for their audiences. Organization of Hepatitis Day in the Alpine Arc (information and screening actions in collaboration with analysis laboratories and CEGIDDs, stands, meetings to update … Type: | 2 | 0 | 0 | 4 |
 | Scemed by Winncare [Automatic translation follows] Improving the lives of people who are losing their autonomy and those who care for them. A major player in the medical equipment market in France, Scemed by Winncare is a specialist in hygiene, transfer and disinfection equipment in healthcare facilities. SCEMED develops innovative concepts that provide real solutions for improving patient care and improving the working conditions of healthcare staff. Our worlds: - HYGIENE: medicalized bathtubs, well-being, therapeutic - SHOWER EQUIPMENT: shower trolleys and chairs, bariatric range - TRANSFER: ceiling rail system, verticalizers, mobile patient lifts, harnesses - DISINFECTION: washer-disinfector, layout and storage solutions Our product … Type: | 4 | 3 | 3 | 42 |
 | Laboratoires BIOTIC Phocea [Automatic translation follows] Innovative solutions in dermo-pigmentation and cosmetics Created by Doctor Tiziano in 1999, BIOTIC Phocea Laboratories offer recognized expertise in restorative and corrective dermopigmentation. Based in Marseille, the laboratories specialize in the design and manufacture of sterile pigments. These meet both European standards for CEIIb Medical Devices (BioChromaDerm®) and the most recent European recommendations in terms of Permanent Makeup. Over the years, BIOTIC Phocea has established itself as the reference on the French market for pigments for medical dermo-pigmentation and permanent makeup. medical dermopigmentation, permanent makeup, organic cosmetics, training, and cosmetic subcontracting Type: | 1 | 0 | 1 | 30 |
 | ACM Pharma [Automatic translation follows] Your specialized partner in contamination control Laboratory for microbiological analysis of health products. Located in the heart of the Centre Val de Loire region near the major pharmaceutical and cosmetic centers, the microbiology laboratory, run by specialized pharmacists and scientists, brings its know-how and more than 10 years of experience to the service of the pharmaceutical industries, manufacturers of medical and cosmetic devices. Analyses carried out within the laboratory: Microbial contamination, endotoxins, sterility testing, bacterial identification, antibiotics, water analysis, challenge tests, testing of antiseptics and disinfectants. Microbiology laboratory, Monitoring of clean rooms, Challenge test, Bacterial identification, Endotoxin, … Type: | 0 | 0 | 0 | 58 |
 | Scaleo Medical SCALEO® Medical conceptualizes, develops and manufactures high-tech CE certified medical devices. Our goal is to build a successful and high technology company in the medical field, providing the best care and effective product solutions for the nursing staff and the patients. SCALEO Medical invents, develops and manufactures innovative products in the fields of patient transfer and hygiene, respiratory and medical weighing equipments. We are committed to helping our patients by developing safer and more effective products for more specialized care. We want to highlight quality products and references that will convince by their efficiency and reliability. We are committed to … Type: | 2 | 0 | 2 | 44 |
 | LABORATOIRE POLIDIS [Automatic translation follows] Founded in 1986, Laboratoire POLIDIS is a human-sized company that has built its reputation in the field of medical devices. Its recognized expertise in the world of condoms also extends to pregnancy tests, ovulation tests, pain relief gels, food supplements as well as a wide range of anti-lice and nit products (shampoo, care cream, two-phase lotion and nit remover). Its status as a French manufacturer and the excellent reputation of its products make Laboratoire POLIDIS a privileged partner of the French Pharmacy. Innovation is the key to success. This is why we ask our teams for the … Type: | 0 | 0 | 0 | 15 |
 | Hôpital Privé La Casamance [Automatic translation follows] 160 liberal practitioners with many specialties practice there thanks to a high-level technical infrastructure. In addition, multidisciplinary medical teams provide safe care for hospitalized or emergency patients 24 hours a day. 500 health professionals are present daily with patients. The establishment, organized into different activity centers, offers a complete care pathway that is broken down into diagnostic, therapeutic and rehabilitation care. Medical and interventional cardiology, Specialty medicine, Specialty surgery, Emergency medicine, Diagnostics, Perinatality, and Follow-up and rehabilitation care Type: | 0 | 0 | 0 | 228 |
 | CeleScreen CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … Type: | 8 | 3 | 5 | 2 |
 | PharmEnable Therapeutics Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI-enabled drug discovery platform, chemSEEK, we explore new chemical spaces and discover novel small molecules with antibody-like specificity and selectivity. We are developing a pipeline of wholly owned therapeutics with initial focus on oncology and neurology. We also engage in drug discovery partnerships across a range of disease areas where accessing the target poses a significant challenge. PharmEnable is based in Cambridge, … Type: | 4 | 1 | 3 | 21 |
 | Hulptroepen Alliantie [Automatic translation follows] Auxiliary Alliance supplies personal protective equipment, rapid tests and antibody tests to healthcare organizations, companies and consumers. Type: | 1 | 1 | 0 | 3 |
 | Röchling Medical Medical plastics solutions for every patient, everywhere, every day We are a preferred supplier and development partner of leading pharmaceutical, biotech and medical technology companies worldwide. Under cleanroom conditions, we manufacture customized pharmaceutical packaging and delivery solutions, consumables for diagnostics, and sophisticated components and assemblies for medical devices. Our customers are pioneers in disease prevention and health restoration. As a reliable partner for integrated solutions, we help to keep it that way. At our sites around the world, we jointly develop innovative and customized plastic products, services, and platform solutions. As a family-owned company, we enable our customers worldwide to … Type: | 0 | 0 | 0 | 285 |
 | Anavex Life Sciences Anavex utilizes genomic biomarkers in precision medicine to treat severe neurological disorders Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease, a Phase 2 proof-of-concept study in Parkinson's disease dementia, and both a Phase 2 and a Phase 3 study … Type: | 1 | 0 | 1 | 53 |
 | Cernostics Providing Deeper Tissue Insights Cernostics has joined Castle Biosciences. Please stay connected! https://www.linkedin.com/company/castle-biosciences-inc-/ Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform … Type: | 0 | 0 | 0 | 552 |
 | PrediTox Your genotoxicity R&D partner PrediTox commits to support its clients in evaluating the genotoxic and potentially carcinogenic properties of their compounds. With more than 10 years of expertise in the study of genotoxicity, the PrediTox team will meet your expectations thanks to its innovative technique as soon as possible. Since our assay adapts to any compounds and can be carry out on any type of human cell lines, we are able to offer you personalized studies. Our goal is to provide quality information to our customers to help you in your R&D works or in your various projects, while reducing … Type: | 1 | 0 | 1 | 3 |
 | PBD Biotech PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. One quarter of the world’s population is infected with latent tuberculosis (LTBI), also known as inactive tuberculosis. One in ten people with LTBI will progress to active TB disease. It is essential to develop newer diagnostic tests with significantly increased predictive value for the development of active disease among those who are infected than the currently available tests for LTBI (WHO, 2017). At PBD Biotech, our mission is to support the scale-up of latent … Type: | 9 | 1 | 5 | 14 |
 | Cumulus Neuroscience Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience. Type: | 9 | 0 | 4 | 32 |
 | Béa Fertility Startup building the first clinical grade fertility treatment | Increasing access to effective and affordable treatments The future of fertility care is here. Affordable, at-home ICI-based fertility treatment designed to help you get you pregnant. Fertility and Medical Device Type: | 3 | 0 | 2 | 16 |
 | Mission Therapeutics Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially … Type: | 6 | 2 | 5 | 36 |
 | Amarin Corporation Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. For more information, visit www.amarincorp.com. See our Community Guidelines: bit.ly/2L7xEW6 Cardiovascular Type: | 1 | 0 | 1 | 459 |
 | vly In our Berlin lab, we develop dairy alternatives that are both nutritious & delicious. Hi, we are vly [flaɪ]. You've probably seen our products before, either in your local supermarket or at the latest here on our LinkedIn. We are the creators of great-tasting dairy alternatives based on pea protein that are also highly nutritious. In fact, we are product developers who experiment with plant protein in the lab every day, generating what we like to call *The Next Generation of Dairy*. Simply because we load our products with nutrients like plant protein, fiber, and healthy fats while using less … Type: | 1 | 0 | 1 | 34 |
 | Bicoll We envision molecules for epilepsy and longevity: Research and development of novel patentable structures. Bicoll is an expert in bioactive plant-derived small molecules with outstanding expertise in high-tech natural product chemistry and validated experience in medicinal chemistry. Currently Bicoll focuses on two main fields such as neurodegenerative disorders (primarily, epilepsy) and longevity. In both of the fields it develops own preclinical candidates. Drug Discovery Services, Custom Synthesis, Medicinal Chemistry Services, Natural Product, Plant-based compounds, Food supplements, Nutraceuticals, and Cosmetics Type: | 2 | 0 | 0 | 14 |
 | SIRION BIOTECH GmbH (Revvity Gene Delivery) Any Gene to Any Cell Viral Vector Services from Vector Engineering and Manufacturing to Cell and Gene Therapy Development Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, our expert team has you covered. For additional information, please visit www.sirion-biotech.com. AAV, Lentivirus, Custom viral vectors, Virus production, AAV engineering for gene therapy, LentiBOOST, and Gene delivery Type: | 0 | 0 | 0 | 39 |
 | BVMed - Bundesverband Medizintechnologie [Automatic translation follows] BVMed is the voice of the German MedTech industry BVMed is the voice of the German MedTech industry. We represent more than 300 manufacturers, suppliers and dealers in the MedTech industry as well as medical device providers and homecare providers. About the industry: 265,000 employees | 93% SMEs | +40 billion € total turnover | 9% investment in R&D | 68% export Imprint: bvmed.de/impressum Medical devices, medical technology, CE marking, reimbursement, market access, reimbursement, benefit assessment, regulatory issues, and health policy Type: | 1 | 0 | 1 | 39 |
 | Tubulis GmbH Reimagining ADCs. Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets. Antibody Drug Conjugates, Targeted Therapy, Biotechnology, and Drug Development Type: | 2 | 1 | 1 | 46 |
 | INFEX Therapeutics Vital new drugs for pandemic infections We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections. Pharmaceuticals, R&D, Antimicrobial Resistance, and Development Type: | 3 | 0 | 0 | 22 |
 | Sirona Biochem Corp. Advancing chemistry. Enhancing health. Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem (located in France) is the recipient of multiple French scientific awards and European Union and French government grants. Sirona Biochem is a publicly-traded company. The company is listed on the TSX Venture Exchange in Canada … Type: | 4 | 0 | 3 | 6 |
 | h/p/cosmos sports & medical gmbh ...run ahead of time! Performance diagnostics, exercise physiology, sports science, sports medicine, biomechanics, motion analysis, athletic training, fitness, CPET, neurologic and orthopedic diagnostics and rehabilitation devives and systems are in the focus of the German based manufacturer h/p/cosmos. Your treadmill specialist and ahead of time since 1988. h/p/cosmos stands for convincing technology, advanced design and safety in the production of running machines, treadmills, ladder-ergometers, sprint trainers (sprint ergometers), sports performance training and diagnostic systems as well as rehabilitation equipment. In the course of time, h/p/cosmos developed into a specialist for running machines and accessories in sports, medicine and research. Designed … Type: | 1 | 0 | 1 | 29 |
 | GTP Bioways Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing Type: | 21 | 5 | 20 | 136 |
 | Tebubio Facilitators of Life Sciences Research Our vision of helping to advance Life Sciences research every day, is embodied by providing a unique, holistic range of solutions to make your life easier – simply and quickly accessible. The full scope of your needs is at the center of our attention. Our experts provide reliable, multimodal solutions, encompassing our extensive range of products, in-house laboratory platforms, and our practical administrative and logistics services. You’ll find the right combination of answers to accelerate your daily work – in one place. Every day, you’ll benefit from our distinctive solutions, from simplified ordering with personalized … Type: | 14 | 2 | 12 | 82 |
 | osteobionix From replacement to regeneration osteobionix is a company dedicated to advancing the standards of care for people suffering from cartilage or bone loss. Cartilage and bone loss may result from a variety of causes including osteoarthritis, trauma and tumor and can severely affect a person’s lifestyle. osteobionix wants to provide people suffering from cartilage or bone loss with innovative, high quality, proven, customized solutions, which can help them regain the lifestyle they deserve. osteobionix collaborates with surgeons in designing and manufacturing reliable, cost-effective solutions, which take into account the uniqueness and complexity of each single surgical case. osteobionix strives to … Type: | 0 | 0 | 0 | 10 |
 | DNANUDGE Nudging your everyday choices through your DNA plus your lifestyle. Buy in-store and online now. DnaNudge is the developer of the world’s first service to use consumers’ own DNA plus lifestyle factors to nudge people towards healthier choices while shopping. The DnaNudge service analyses and maps users’ genetic profile to key nutrition-related health traits such as obesity, diabetes, hypertension and cholesterol, enabling customers to be guided by their DNA towards healthier eating. The service has been developed by world-renowned biomedical engineer Regius Professor Chris Toumazou FRS and published geneticist Dr Maria Karvela. This ground-breaking in-store DNA testing service created to … Type: | 5 | 1 | 3 | 53 |
 | Colorifix Unlocking nature's pigments for the global dyeing industry We bring colour to life. Colorifix has developed a revolutionary dyeing process to help the textile industry dramatically reduce its environmental impact in a cost-effective manner. Using synthetic biology we produce, deposit and fix dyes biologically, avoiding harmful chemicals whilst reducing water, energy and waste. Let's rethink industrial dyeing. Contact us today to discuss how Colorifix can fulfil your coloration requirements. Type: | 9 | 4 | 8 | 90 |
 | ANGLE The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. … Type: | 1 | 1 | 0 | 154 |
 | TrakCel Transforming Cellular Orchestration for Cell & Gene Therapy. Join us. See the journey. TrakCel design, deploy and support digital Cellular Orchestration Solutions that track and manage all the components of the Cell and Gene Therapy supply chain, helping therapy developers to deliver therapies to patients safely and efficiently for both clinical and commercial stage therapies. For each Advance Therapy Patient journey, from sample collection through logistics, manufacturing and final treatment, TrakCel's flagship platform, OCELLOS orchestrates every step, providing a comprehensive chain of custody, chain of identity and traceability throughout. Always remembering there is a patient at the end of everything … Type: | 2 | 0 | 2 | 93 |
 | Nextep Health Cabinet de conseil en stratégie spécialisé dans les problématiques de santé Nextep, a catalyst for ideas and expertise : "When all healthcare players want to create more value for patients " Founded in 1999, Nextep is an independent healthcare consultancy firm specialized in 6 complementary practices: Strategy & Performance; Business Development; Public Affairs & Strategic communication; Market Access & Health Economics; Training; Publishing Specialized in strategic health issues. Our interventions for customers throughout Europe and the United States are intended to support managers – from innovative SMEs to multinationals – in their development, both in medicine, biotech, the “medical device” … Type: | 18 | 3 | 15 | 49 |
 | Microbiotica Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche … Type: | 6 | 1 | 1 | 50 |
 | Vect-Horus Enhancing the transport of therapeutic and imaging agents using versatile and flexible targeting technologies VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which limit access of therapeutic or imaging agents to their targets. The proof of concept of the technology has already been established in animal models using different vectorized molecules. Vect-Horus endorces a mixed business model, based … Type: | 23 | 6 | 8 | 43 |
 | BASF Pharma Solutions Inspiring Medicines for better Lives BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of industry experts and digital solutions, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, we have the knowledge and resources to make pharmaceutical drug delivery and the manufacturing of drugs and biologics safer and more sustainable. We create solutions for Biopharma, Parenteral, Oral, Solubilization and Topical applications and are also a leading supplier of selected APIs such as ibuprofen, L-menthol and Omega-3. About BASF … Type: | 1 | 0 | 1 | 0 |
 | TME Pharma Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor microenvironment (TME) TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. TME Pharma’s mission is to improve treatment outcomes for patients … Type: | 4 | 1 | 2 | 19 |
SMB